Adaptimmune Therapeutics PLC Quarterly Current Ratio in % from Q3 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Adaptimmune Therapeutics PLC quarterly Current Ratio history and growth rate from Q3 2016 to Q3 2024.
  • Adaptimmune Therapeutics PLC Current Ratio for the quarter ending September 30, 2024 was 313 %, a 7.84% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 313 -26.7 -7.84% Sep 30, 2024
Q2 2024 293 -75.4 -20.5% Jun 30, 2024
Q1 2024 301 -92.2 -23.4% Mar 31, 2024
Q4 2023 314 -130 -29.3% Dec 31, 2023
Q3 2023 340 -167 -32.9% Sep 30, 2023
Q2 2023 368 -206 -35.8% Jun 30, 2023
Q1 2023 394 -275 -41.1% Mar 31, 2023
Q4 2022 444 -357 -44.6% Dec 31, 2022
Q3 2022 507 -406 -44.5% Sep 30, 2022
Q2 2022 574 -464 -44.7% Jun 30, 2022
Q1 2022 669 -473 -41.4% Mar 31, 2022
Q4 2021 801 -261 -24.6% Dec 31, 2021
Q3 2021 912 +16.3 +1.82% Sep 30, 2021
Q2 2021 1.04K +357 +52.4% Jun 30, 2021
Q1 2021 1.14K +626 +121% Mar 31, 2021
Q4 2020 1.06K +541 +104% Dec 31, 2020
Q3 2020 896 +233 +35% Sep 30, 2020
Q2 2020 680 -141 -17.1% Jun 30, 2020
Q1 2020 516 -197 -27.7% Mar 31, 2020
Q4 2019 521 -52.7 -9.2% Dec 31, 2019
Q3 2019 663 +235 +54.8% Sep 30, 2019
Q2 2019 821 +466 +131% Jun 30, 2019
Q1 2019 714 +306 +75.1% Mar 31, 2019
Q4 2018 573 +113 +24.5% Dec 31, 2018
Q3 2018 429 -105 -19.8% Sep 30, 2018
Q2 2018 355 -332 -48.3% Jun 30, 2018
Q1 2018 408 -322 -44.2% Mar 31, 2018
Q4 2017 461 -370 -44.5% Dec 31, 2017
Q3 2017 534 -481 -47.4% Sep 30, 2017
Q2 2017 687 Jun 30, 2017
Q1 2017 730 Mar 31, 2017
Q4 2016 831 Dec 31, 2016
Q3 2016 1.02K Sep 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.